EGRX : Summary for Eagle Pharmaceuticals, Inc. - Yahoo Finance

U.S. Markets open in 2 hrs 43 mins

Eagle Pharmaceuticals, Inc. (EGRX)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
69.31+2.94 (+4.43%)
At close: 4:00PM EST
People also watch
ALDRFLXNRTRXESPRRDUS
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close66.37
Open65.93
Bid0.00 x
Ask0.00 x
Day's Range65.78 - 70.16
52 Week Range33.02 - 87.78
Volume729,261
Avg. Volume423,708
Market Cap1.07B
BetaN/A
PE Ratio (TTM)45.12
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Eagle Pharmaceuticals, Inc. – Value Analysis (NASDAQ:EGRX) : January 10, 2017
    Capital Cube6 days ago

    Eagle Pharmaceuticals, Inc. – Value Analysis (NASDAQ:EGRX) : January 10, 2017

    Categories: Fundamental Analysis Yahoo Finance Click here to see latest analysis Capitalcube gives Eagle Pharmaceuticals, Inc. a score of 89. Our analysis is based on comparing Eagle Pharmaceuticals, Inc. with the following peers – Madrigal Pharmaceuticals, Inc., Johnson & Johnson, GlaxoSmithKline plc Sponsored ADR, Medicines Company, Novartis AG Sponsored ADR, Teva Pharmaceutical Industries Limited Sponsored ADR, Bristol-Myers Squibb Company, Amgen ... Read more (Read more...)

  • Eagle Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : EGRX-US : January 9, 2017
    Capital Cube7 days ago

    Eagle Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : EGRX-US : January 9, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Eagle Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more (Read more...)

  • Business Wire12 days ago

    Eagle Pharmaceuticals to Present at J.P. Morgan 35th Annual Healthcare Conference

    Eagle Pharmaceuticals, Inc. announced today that Scott Tarriff, Chief Executive Officer, and David Riggs, Chief Financial Officer, will present at the J.P. Morgan 35t